Inna V Kriger

Title: Inna V Kriger: Innovator in Tuberculosis Treatment

Introduction

Inna V Kriger is a notable inventor based in College Station, TX (US). She has made significant contributions to the field of medical research, particularly in the development of treatments for tuberculosis. Her innovative work focuses on the inhibition of mycobacterial malate synthase, a crucial enzyme in the survival of Mycobacterium tuberculosis.

Latest Patents

Inna V Kriger holds a patent for "Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof." This invention provides aryl- or heteroaryl-diketo acid compounds that effectively inhibit the activity of the Mycobacterial malate synthase enzyme. The compounds may include phenyl-, naphthyl-, or thienyl-substituted diketo acids and their carboxylate derivatives. The patent also outlines methods for treating tuberculosis and other conditions associated with malate synthase activity, along with in silico design methods for these inhibitory compounds. Additionally, it includes three-dimensional X-ray crystal structures of the Mycobacterial malate synthase complexed with the inhibitory compounds.

Career Highlights

Inna V Kriger is affiliated with the Texas A&M University System, where she continues her research and development efforts. Her work has garnered attention for its potential impact on public health, particularly in combating tuberculosis, a disease that remains a significant global health challenge.

Collaborations

Inna has collaborated with esteemed colleagues such as Thomas R Ioerger and James C Sacchettini. Their combined expertise enhances the research efforts and contributes to the advancement of innovative solutions in the field.

Conclusion

Inna V Kriger's contributions to the field of tuberculosis treatment through her innovative patent demonstrate her commitment to addressing critical health issues. Her work exemplifies the importance of research and collaboration in the fight against infectious diseases.